Kymera Therapeutics
KYMR
#3681
Rank
HK$22.05 B
Marketcap
HK$340.51
Share price
-0.68%
Change (1 day)
109.18%
Change (1 year)

Kymera Therapeutics (KYMR) - Cash on Hand

Cash on Hand as of September 2024 : HK$4.28 Billion

According to Kymera Therapeutics's latest financial reports the company has HK$4.28 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Kymera Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$2.92 B-7.97%
2022-12-31HK$3.18 B-7.78%
2021-12-31HK$3.44 B50.24%
2020-12-31HK$2.29 B220.62%
2019-12-31HK$0.71 B121.65%
2018-12-31HK$0.32 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$2.22 B-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA